A. Ceccato (barcelona, Spain), C. Cilloniz Campos (Barcelona, Spain)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Long-term impact of DRIP score on antibiotic stewardship in patients with community acquired pneumonia
J. Carr (Salt Lake City, United States of America), M. Lanspa (Salt Lake City, United States of America), B. Webb (Salt Lake City, United States of America), N. Dean (Salt Lake City, United States of America)
|   |
Prime-boost, double-dose immunization and immunity to influenza vaccination in COPD
G. Anderson (Parkville, Australia), L. Irving (Parkville, Australia), A. Jarnicki (Parkville, Australia), K. Kedzierska (Parkville, Australia), M. Koutsakos (Parkville, Australia), S. Kent (Parkville, Australia), A. Hurt (Parkville, Australia), A. Wheatley (Parkville, Australia), T. Nguyen (Parkville, Australia), N. Snape (Brisbane, Australia), J. Upham (Brisbane, Australia)
| |
Outcomes of Critically ill Very old patients with Acute Respiratory Distress Syndrome and Community-Acquired Pneumonia
C. Cilloniz Campos (Barcelona, Spain), J. Pericas (Barcelona, Spain), H. Peroni (Buenos Aires, Argentina), A. Gabarrus (Barcelona, Spain), E. Barbeta (Barcelona, Spain), A. Palomeque (Barcelona, Spain), M. Ferrer (Barcelona, Spain), A. Torres (Barcelona, Spain)
| |
Severity of community-acquired-pneumonia in elderly.
A. Ghourabi (Ariana, Tunisia), I. Zendah (Ariana, Tunisia), C. Moussa (Ariana, Tunisia), H. Rouis (Ariana, Tunisia), N. Mahmoud (Ariana, Tunisia), S. Debbiche (Ariana, Tunisia), A. Zaoui (Ariana, Tunisia), I. Khouaja (Ariana, Tunisia), A. Khattab (Ariana, Tunisia), L. Bayahi (Ariana, Tunisia), H. Ghedira (Ariana, Tunisia)
| |
Respiratory tract infection in centenarians
C. Yu (Melbourne, Australia), A. Aung (Melbourne, Australia), C. Foo (Melbourne, Australia)
| |
The impact of Healthcare-Associated Pneumonia in patients admitted in a Northern Portuguese hospital
L. Méndez González (Santa Maria da Feira, Portugal), P. Castro (Santa Maria da Feira, Portugal), C. Caneiras (Lisbon, Portugal)
| |
VAP: Clinicoradiological and microbiological profile & risk-factors for MDR bacterial infection
S. Nandy (Kolkata, India), A. Datta Chaudhuri (Kolkata, India), S. Roy Tapadar (Kolkata, India)
| |
Particularities of pneumonia in diabetes patients.
A. Ghourabi (Ariana, Tunisia), C. Moussa (Ariana, Tunisia), H. Rouis (Ariana, Tunisia), S. Debbiche (Ariana, Tunisia), N. Mahmoud (Ariana, Tunisia), A. Zaouia (Ariana, Tunisia), A. Khattab (Ariana, Tunisia), I. Khouaja (Ariana, Tunisia), I. Zendah (Ariana, Tunisia), H. Ghedira (Ariana, Tunisia)
| |
An Audit of Hospital in the Home Treatment in Respiratory Patients
M. Said (Victoria, Australia), P. King (Victoria, Australia)
| |
A STUDY OF CLINICORADIOLOGICAL AND MICROBIOLOGICAL PROFILE AND BIOMARKERS IN CASES OF COMMUNITY ACQUIRED PNEUMONIA ADMITTED IN A TERTIARY CARE HOSPITAL
B. HATI (Berhampore, India), A. Dey (UTTARPARA, India), S. Bhattacharya (KOLKATA, India), M. Chatterjee (KOLKATA, India)
| |
Lymphopenic community acquired pneumococcal pneumonia: Clinical characteristics and outcome
L. Ruiz Iturriaga (Barakaldo (Bizkaia), Spain), L. Serrano Fernandez (Barakaldo (Bizkaia), Spain), B. Gonzalez Quero (Barakaldo (Bizkaia), Spain), A. Gomez Bonilla (Barakaldo (Bizkaia), Spain), S. Perez Fernandez (Barakaldo (Bizkaia), Spain), A. Rezola Carasusan (Barakaldo (Bizkaia), Spain), A. Artaraz Ereño (Galdakao (Bizkaia), Spain), J. Solorzano Santobeña (Barakaldo (Bizkaia), Spain), I. Gonzalez Muñoz (Barakaldo (Bizkaia), Spain), P. España Yandiola (Galdakao (Bizkaia), Spain), R. Zalacain Jorge (Barakaldo (Bizkaia), Spain)
| |
Bacteraemic pneumococcal pneumonia and SARS-CoV-2 pneumonia: differences and similarities
L. Serrano Fernandez (Barakaldo (Bizkaia), Spain), L. Ruiz Iturriaga (Barakaldo (Bizkaia), Spain), P. España Yandiola (Galdakao (Bizkaia), Spain), R. Mendez Ocaña (Valencia, Spain), S. Perez Fernandez (Barakaldo (Bizkaia), Spain), E. Tabernero Huget (Barakaldo (Bizkaia), Spain), A. Uranga Echeverria (Galdakao (Bizkaia), Spain), P. Gonzalez Jimenez (Valencia, Spain), P. Garcia Hontoria (Galdakao (Bizkaia), Spain), R. Menendez Villanueva (Valencia, Spain), R. Zalacain Jorge (Barakaldo (Bizkaia), Spain)
| |
Trends in mortality from lower respiratory tract infections in Greece (1998-2015)
I. Lampropoulos (Patra, Greece), D. Raptis (Larissa, Greece), G. Perlepe (Larissa, Greece), Z. Daniil (Larissa, Greece), I. Papathanasiou (Larissa, Greece), K. Gourgoulianis (Larissa, Greece), F. Malli (Larisa, Greece)
| |
The predictive validity for mortality in community-acquired pneumonia of qSOFA was greater than IDSA/ATS minor criteria
Q. Guo (Shenzhen (Guangdong), China), H. Li (Shenzhen (Guangdong), China), W. Song (Shenzhen (Guangdong), China), M. Li (Shenzhen (Guangdong), China), X. Chen (Shenzhen (Guangdong), China), H. Liu (Shenzhen (Guangdong), China), H. Peng (Shenzhen (Guangdong), China), H. Yu (Shenzhen (Guangdong), China), N. Liu (Shenzhen (Guangdong), China), Y. Li (Shenzhen (Guangdong), China), Z. Lü (Shenzhen (Guangdong), China), L. Liang (Shenzhen (Guangdong), China), . Zhao (Shenzhen (Guangdong), China), M. Jiang (Shenzhen (Guangdong), China)
| |
Impact on in-hospital mortality of Ceftaroline versus standard of care in Community-Acquired Pneumonia: A Propensity Matched Analysis
C. Cilloniz Campos (Barcelona, Spain), R. Mendez (Valencia, Spain), H. Peroni (Buenos Aires, Argentina), C. Garcia-Vidal (Barcelona, Spain), V. Rico (Barcelona, Spain), R. Menendez (Barcelona, Spain), A. Torres (Barcelona, Spain), A. Soriano (Barcelona, Spain)
| |
Outcomes reported in pneumonia randomized controlled trials
A. Mathioudakis (Manchester, United Kingdom), M. Fally (Hellerup, Denmark), R. Robey (Manchester, United Kingdom), T. Willams (Manchester, United Kingdom), F. Haseeb (Manchester, United Kingdom), A. Kouta (Manchester, United Kingdom), P. Dark (Manchester, United Kingdom), A. Bentley (Manchester, United Kingdom), J. Vestbo (Manchester, United Kingdom), T. Felton (Manchester, United Kingdom)
| |
Performance of the CORB score for predicting clinical outcomes in community-acquired pneumonia.
A. Bastidas (Chia, Colombia), K. Pedreros (Chia, Colombia), M. Herrera (Chia, Colombia), J. Frias (Chia, Colombia), A. Aguilar (Chia, Colombia), L. Saza (Chia, Colombia), A. Nonzoque (Chia, Colombia), L. Bello (Chia, Colombia), M. Hernandez (Chia, Colombia), G. Camargo (Chia, Colombia), A. Jaimes (Chia, Colombia), S. Ramirez (Chia, Colombia), N. Murillo (Chia, Colombia), L. Reyes (Chia, Colombia), K. Pedreros Suarez (Bogotá, Colombia)
| |
Hospital aquired pneumonia- what's the score? A scoping & observational study on severity scoring indicies in HAP
M. Peirson (Beverley, United Kingdom), P. Kempster (Bangor, United Kingdom), S. Williams (Bangor, United Kingdom), D. Mckeon (Bangor, United Kingdom)
| |
Rapid syndromic PCR testing in a Norwegian cohort with suspected community acquired pneumonia
S. Serigstad (Bergen, Norway), H. Grewal (Bergen, Norway), M. Ebbesen (Bergen, Norway), Ø. Kommedal (Bergen, Norway), D. Markussen (Bergen, Norway), L. Heggelund (Drammen, Norway), D. Faurholt-Jepsen (Copenhagen, Denmark), C. Ritz (Copenhagen, Denmark), E. Ulvestad (Bergen, Norway), R. Bjørneklett (Bergen, Norway), S. Knoop (Bergen, Norway), .. Capnor Study Group* (Bergen, Norway)
| |
Can sputum induction aid in identifying micro-organisms that cause respiratory tract infections other than tuberculosis? A tertiary care hospital experience.
A. Khan (Riyadh , Saudi Arabia), H. Al-Jahdali (Riyadh , Saudi Arabia), A. Harbi (Riyadh , Saudi Arabia), R. Rajendram (Riyadh , Saudi Arabia), A. Suliman (Riyadh , Saudi Arabia), S. Nahid (Medina, Saudi Arabia), M. Alhamadi (Riyadh , Saudi Arabia), A. Al-Rashidi (Riyadh , Saudi Arabia)
| |